Erectile dysfunction decisions — 2024

The Board has denied service connection for PTSD and increased rating for diabetes mellitus type II and erectile dysfunction (diabetes), but has remanded the claim of service connection for tinnitus due to a duty-to-assist error.

The Veteran's prostate cancer and ischemic heart disease are granted service connection due to presumed exposure to herbicide agents. The erectile dysfunction is also granted as secondary to the service-connected prostate cancer.

The Veteran's claims for service connection for erectile dysfunction, overactive bladder, and dyspepsia/gastroesophageal reflux disease (GERD) as secondary to his service-connected hypertension are remanded due to insufficient information in the record.

The Veteran's appeals for increased disability ratings were dismissed due to his death. The Board has no jurisdiction to adjudicate the merits of these claims as he died during the appeal process.

The Veteran's erectile dysfunction is granted as secondary to his service-connected PTSD.,The Veteran's right foot condition, including hammer toes and osteoarthritis, is remanded due to lack of in-service records.

The Veteran's claim for service connection for PTSD has been dismissed. The Board finds that the criteria to dismiss the claim have been met. The Veteran's claim of service connection for erectile dysfunction is remanded.

The Board has granted earlier effective dates of September 25, 2019 for the grant of service connection for prostate cancer and erectile dysfunction (ED), as well as basic eligibility to Dependents' Educational Assistance (DEA). The Veteran's claim was initially denied in February 2020 but was later reconsidered due to a request for higher-level review filed during the COVID-19 pandemic.,The Board also granted special monthly compensation (SMC) based on loss of use of a creative organ, as this decision is granting an earlier effective date of September 25, 2019.

The Board has decided that a remand is required due to an inadequate VA opinion regarding the etiology of the Veteran's erectile dysfunction, which may be aggravated by his service-connected adjustment disorder with depressed mood and medications used to treat it.

The Board has determined that the Veteran's erectile dysfunction is not related to his military service and therefore denied his claim for service connection.

The Veteran's neuroendocrine tumor with carcinoid syndrome, heart valve replacement, and erectile dysfunction are being remanded for further development due to pre-decisional duty-to-assist errors. The claims will be adjudicated together as they are inextricably intertwined.

The Board has decided to remand the case due to an inadequate medical opinion regarding whether the Veteran's ED is secondary to his service-connected bipolar disorder. The VA will obtain a new medical opinion to address this issue.

The Board has remanded the Veteran's claims for service connection, effective dates, and ratings related to coronary artery disease with chronic congestive heart failure, erectile dysfunction, loss of use of a creative organ, and epididymo-orchitis due to outstanding VA treatment records.

The Veteran's initial 20% disability rating for prostate cancer residuals, including awakening to void three times per night, is granted effective October 22, 2021. The effective date of service connection for erectile dysfunction is also set at October 22, 2021.

The Board denied the appellant's eligibility for attorney fees based on past-due benefits awarded in the March 2023 rating decision because the claims were not previously adjudicated and no representation was provided prior to the initial decision.

The Veteran withdrew his appeal, so the case is dismissed.

The Board has granted an earlier effective date of January 23, 2017 for the grant of service connection for Erectile Dysfunction (ED) associated with Adenocarcinoma of the Prostate and corresponding Special Monthly Compensation (SMC). The decision is based on the fact that the Veteran's ED was shown to be due to treatment for prostate cancer which began in or around January 2017.

The Board has denied compensable ratings for bladder cancer and hypertension, and service connection for erectile dysfunction. The case is being remanded to obtain a new VA examination.

New evidence has been submitted that may support the Veteran's claims for service connection. The AOJ will review these new claims and determine if they meet the criteria for service connection.

The Veteran has withdrawn his appeals for left foot tendonitis/arthritis, right foot tendonitis/arthritis, erectile dysfunction, and hypertension. The appeal is dismissed.

The Board denied service connection for erectile dysfunction, finding that the evidence did not support a link to active service or a service-connected disability.